Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Freedman

Showing results (61-70 of 179) with videos related to

Pageof 18
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survivalPaul L Nguyen, Jing Ma, Jorge E Chavarro, et al.
Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.
Cancer Letters|August 19, 2025
Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stressAkash Sabarwal, Marc Machaalani, Laxminarayan Rawat, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Iscience|July 16, 2019
Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian CancerXianzhi Lin, Tassja J Spindler, Marcos Abraão de Souza Fonseca, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2010
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYCNasim Ahmadiyeh, Mark M Pomerantz, Chiara Grisanzio, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2006
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American menMatthew L Freedman, Christopher A Haiman, Nick Patterson, et al.
Cancer|June 14, 2017
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancerMark M Pomerantz, Sandor Spisák, Li Jia, et al.
Nature Medicine|September 24, 2015
CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variantsSándor Spisák, Kate Lawrenson, Yanfang Fu, et al.
JCO Precision Oncology|September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate CancerJacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Pageof 18

Showing results (61-70 of 179) with videos related to

Sort By:
Pageof 18
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2010
Fatty acid synthase polymorphisms, tumor expression, body mass index, prostate cancer risk, and survivalPaul L Nguyen, Jing Ma, Jorge E Chavarro, et al.
Nature Genetics|October 13, 2015
The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesisMark M Pomerantz, Fugen Li, David Y Takeda, et al.
Cancer Letters|August 19, 2025
Targeting AXL can effectively overcome c-Met-induced therapeutic resistance in renal cancer and promote tumor cell death through increased oxidative stressAkash Sabarwal, Marc Machaalani, Laxminarayan Rawat, et al.
Nature Genetics|April 26, 2022
HOXB13 suppresses de novo lipogenesis through HDAC3-mediated epigenetic reprogramming in prostate cancerXiaodong Lu, Ka-Wing Fong, Galina Gritsina, et al.
Iscience|July 16, 2019
Super-Enhancer-Associated LncRNA UCA1 Interacts Directly with AMOT to Activate YAP Target Genes in Epithelial Ovarian CancerXianzhi Lin, Tassja J Spindler, Marcos Abraão de Souza Fonseca, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2010
8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYCNasim Ahmadiyeh, Mark M Pomerantz, Chiara Grisanzio, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 2, 2006
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American menMatthew L Freedman, Christopher A Haiman, Nick Patterson, et al.
Cancer|June 14, 2017
The association between germline BRCA2 variants and sensitivity to platinum-based chemotherapy among men with metastatic prostate cancerMark M Pomerantz, Sandor Spisák, Li Jia, et al.
Nature Medicine|September 24, 2015
CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variantsSándor Spisák, Kate Lawrenson, Yanfang Fu, et al.
JCO Precision Oncology|September 14, 2022
Addition of Germline Testing to Tumor-Only Sequencing Improves Detection of Pathogenic Germline Variants in Men With Advanced Prostate CancerJacob E Berchuck, Daniel Boiarsky, Rebecca Silver, et al.
Pageof 18